《大行報告》高盛上調H&H國際控股(01112.HK)目標價至41.75元 評級「買入」
高盛發表研究報告,指H&H國際(01112.HK)第二季銷售錄低單位數增長,較首季有改善,上半年經調整EBITDA維持在20%,符合其全年目標,及高於去年下半年的13%。
該行指,H&H國際純利於上半年下跌,全年亦相信會受到非現金項目影響約1.4至1.5億元人民幣,所以料按年下跌30至40%。
高盛指,第二季公司Swisse中國的表現有亮點,估計有35%增長,快於首季,當中包括有「618購物節」活動的促銷;嬰兒配方業務見穩定增長,惟保健品見下跌。
該行升H&H國際2021至2023年經常性盈利預期0-2%,以反映最新營運情況,將H&H國際控股目標價由40.2元升至41.75元,維持「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.